Arrowstreet Capital’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-169,898
| Closed | -$16.9M | – | 2393 |
|
|
2020
Q4 | $16.9M | Sell |
169,898
-58,762
| -26% | -$5.84M | 0.02% | 650 |
|
|
2020
Q3 | $21.8M | Buy |
228,660
+69,695
| +44% | +$6.64M | 0.03% | 520 |
|
|
2020
Q2 | $17.8M | Buy |
158,965
+132,085
| +491% | +$14.8M | 0.03% | 548 |
|
|
2020
Q1 | $1.96M | Buy |
+26,880
| New | +$1.96M | 0.01% | 1071 |
|
|
2013
Q4 | – | Sell |
-12,516
| Closed | -$542K | – | 1232 |
|
|
2013
Q3 | $542K | Buy |
+12,516
| New | +$542K | ﹤0.01% | 783 |
|